Race, Ethnicity, and Income Factors Impacting Human Papillomavirus Vaccination rates
Abstract Background Human papillomavirus (HPV) infection and cervical cancer disproportionately affect low-income and minority women. HPV vaccines have the potential to either reduce or exacerbate racial disparities in HPV-related diseases and cervical cancers, depending on the equitability of vacci...
Gespeichert in:
Veröffentlicht in: | Clinical therapeutics 2014, Vol.36 (1), p.24-37 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 37 |
---|---|
container_issue | 1 |
container_start_page | 24 |
container_title | Clinical therapeutics |
container_volume | 36 |
creator | Jeudin, Patricia, MD Liveright, Elizabeth, MD del Carmen, Marcela G., MD Perkins, Rebecca B., MD, MSc |
description | Abstract Background Human papillomavirus (HPV) infection and cervical cancer disproportionately affect low-income and minority women. HPV vaccines have the potential to either reduce or exacerbate racial disparities in HPV-related diseases and cervical cancers, depending on the equitability of vaccine uptake. Objectives This review aims to identify barriers and facilitators of equitable uptake of HPV vaccination among low-income and minority girls. This review discusses factors related to race, ethnicity, and income that are associated with initiation and completion rates of the 3-dose HPV vaccine series and presents targets for intervention. Methods We reviewed relevant English-language literature to identify current vaccination rates and factors associated with vaccine uptake. Study findings related to race (black, Latino, Asian), and incomes were summarized. Results Current trends in the United States indicate low uptake among all adolescents, and that rates stagnated between 2011 and 2012. Low-income and minority adolescents are equally or more likely to start the HPV vaccination series than are white and higher-income adolescents, but are less likely to complete all 3 shots. Provider recommendation is a key factor in HPV vaccination, and minorities are less likely to report receiving recommendations for HPV vaccination. Conclusions As black, Hispanic, and Asian populations continue to grow in the United States over the next several decades, it is imperative that we not only improve HPV vaccination rates overall, but also focus on high-risk populations to prevent an increase in cervical cancer disparities. |
doi_str_mv | 10.1016/j.clinthera.2013.11.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1490698022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0149291813010709</els_id><sourcerecordid>3180614751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-a3ca31f0a54146a6679e71db144ff0d85f2ac5c29afb80dbb453e644bf93fe493</originalsourceid><addsrcrecordid>eNqNksFu1DAQhiMEotvCK0AkhMShCR7bieMLUlW1dKVKICiImzVxbOolcRY7qbRvX0e7tFJPnDyHb8b_fJosewukBAL1x02pe-enWxOwpARYCVASAs-yFTRCFgD81_NsRYDLgkpojrLjGDeEECYr-jI7opyDEA1bZTffUJvT_GK69U67aXeao-_ytdfjYPJL1NMYYr4etqly_nd-NQ_o86-4dX0_Dnjnwhzzn6i18zi50ecBJxNfZS8s9tG8Prwn2Y_Li5vzq-L6y-f1-dl1oZmUU4FMIwNLsOLAa6xrIY2ArgXOrSVdU1mKutJUom0b0rUtr5ipOW-tZNZwyU6yD_u52zD-nU2c1OCiNn2P3oxzVGl9UsuGUJrQd0_QzTgHn9IlSggKlMuFEntKhzHGYKzaBjdg2CkgahGvNupBvFrEKwCVxKfON4f5czuY7qHvn-kEvD8AGDX2NqDXLj5yDRUp6xLhbM-ZJO7OmaCidsZr07lg9KS60f1HmE9PZiycS9_-MTsTHzdXkSqivi93spwJMAJEEMnuATwouao</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1477212492</pqid></control><display><type>article</type><title>Race, Ethnicity, and Income Factors Impacting Human Papillomavirus Vaccination rates</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Jeudin, Patricia, MD ; Liveright, Elizabeth, MD ; del Carmen, Marcela G., MD ; Perkins, Rebecca B., MD, MSc</creator><creatorcontrib>Jeudin, Patricia, MD ; Liveright, Elizabeth, MD ; del Carmen, Marcela G., MD ; Perkins, Rebecca B., MD, MSc</creatorcontrib><description>Abstract Background Human papillomavirus (HPV) infection and cervical cancer disproportionately affect low-income and minority women. HPV vaccines have the potential to either reduce or exacerbate racial disparities in HPV-related diseases and cervical cancers, depending on the equitability of vaccine uptake. Objectives This review aims to identify barriers and facilitators of equitable uptake of HPV vaccination among low-income and minority girls. This review discusses factors related to race, ethnicity, and income that are associated with initiation and completion rates of the 3-dose HPV vaccine series and presents targets for intervention. Methods We reviewed relevant English-language literature to identify current vaccination rates and factors associated with vaccine uptake. Study findings related to race (black, Latino, Asian), and incomes were summarized. Results Current trends in the United States indicate low uptake among all adolescents, and that rates stagnated between 2011 and 2012. Low-income and minority adolescents are equally or more likely to start the HPV vaccination series than are white and higher-income adolescents, but are less likely to complete all 3 shots. Provider recommendation is a key factor in HPV vaccination, and minorities are less likely to report receiving recommendations for HPV vaccination. Conclusions As black, Hispanic, and Asian populations continue to grow in the United States over the next several decades, it is imperative that we not only improve HPV vaccination rates overall, but also focus on high-risk populations to prevent an increase in cervical cancer disparities.</description><identifier>ISSN: 0149-2918</identifier><identifier>EISSN: 1879-114X</identifier><identifier>DOI: 10.1016/j.clinthera.2013.11.001</identifier><identifier>PMID: 24417783</identifier><language>eng</language><publisher>Bridgewater, NJ: Elsevier Inc</publisher><subject><![CDATA[Adolescent ; Biological and medical sciences ; Cervical cancer ; Ethnic Groups - education ; Ethnic Groups - statistics & numerical data ; ethnicity ; Female ; Health insurance ; HPV ; Human papillomavirus ; Humans ; Immunization ; Immunization Programs - economics ; Immunization Programs - statistics & numerical data ; Immunization Programs - trends ; income ; Infectious diseases ; Internal Medicine ; Male ; Medical Education ; Medical sciences ; Papillomavirus Infections - ethnology ; Papillomavirus Infections - prevention & control ; Papillomavirus Vaccines - administration & dosage ; Papillomavirus Vaccines - economics ; Pharmacology. Drug treatments ; Poverty - economics ; Poverty - statistics & numerical data ; race ; racial disparities ; Teenagers ; Uterine Cervical Neoplasms - ethnology ; Uterine Cervical Neoplasms - prevention & control ; vaccination ; Vaccines ; Viral diseases]]></subject><ispartof>Clinical therapeutics, 2014, Vol.36 (1), p.24-37</ispartof><rights>Elsevier HS Journals, Inc.</rights><rights>2014 Elsevier HS Journals, Inc.</rights><rights>2015 INIST-CNRS</rights><rights>2014 Published by Elsevier HS Journals, Inc.</rights><rights>Copyright Elsevier Limited Jan 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-a3ca31f0a54146a6679e71db144ff0d85f2ac5c29afb80dbb453e644bf93fe493</citedby><cites>FETCH-LOGICAL-c399t-a3ca31f0a54146a6679e71db144ff0d85f2ac5c29afb80dbb453e644bf93fe493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0149291813010709$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,4010,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28270692$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24417783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jeudin, Patricia, MD</creatorcontrib><creatorcontrib>Liveright, Elizabeth, MD</creatorcontrib><creatorcontrib>del Carmen, Marcela G., MD</creatorcontrib><creatorcontrib>Perkins, Rebecca B., MD, MSc</creatorcontrib><title>Race, Ethnicity, and Income Factors Impacting Human Papillomavirus Vaccination rates</title><title>Clinical therapeutics</title><addtitle>Clin Ther</addtitle><description>Abstract Background Human papillomavirus (HPV) infection and cervical cancer disproportionately affect low-income and minority women. HPV vaccines have the potential to either reduce or exacerbate racial disparities in HPV-related diseases and cervical cancers, depending on the equitability of vaccine uptake. Objectives This review aims to identify barriers and facilitators of equitable uptake of HPV vaccination among low-income and minority girls. This review discusses factors related to race, ethnicity, and income that are associated with initiation and completion rates of the 3-dose HPV vaccine series and presents targets for intervention. Methods We reviewed relevant English-language literature to identify current vaccination rates and factors associated with vaccine uptake. Study findings related to race (black, Latino, Asian), and incomes were summarized. Results Current trends in the United States indicate low uptake among all adolescents, and that rates stagnated between 2011 and 2012. Low-income and minority adolescents are equally or more likely to start the HPV vaccination series than are white and higher-income adolescents, but are less likely to complete all 3 shots. Provider recommendation is a key factor in HPV vaccination, and minorities are less likely to report receiving recommendations for HPV vaccination. Conclusions As black, Hispanic, and Asian populations continue to grow in the United States over the next several decades, it is imperative that we not only improve HPV vaccination rates overall, but also focus on high-risk populations to prevent an increase in cervical cancer disparities.</description><subject>Adolescent</subject><subject>Biological and medical sciences</subject><subject>Cervical cancer</subject><subject>Ethnic Groups - education</subject><subject>Ethnic Groups - statistics & numerical data</subject><subject>ethnicity</subject><subject>Female</subject><subject>Health insurance</subject><subject>HPV</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization Programs - economics</subject><subject>Immunization Programs - statistics & numerical data</subject><subject>Immunization Programs - trends</subject><subject>income</subject><subject>Infectious diseases</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical Education</subject><subject>Medical sciences</subject><subject>Papillomavirus Infections - ethnology</subject><subject>Papillomavirus Infections - prevention & control</subject><subject>Papillomavirus Vaccines - administration & dosage</subject><subject>Papillomavirus Vaccines - economics</subject><subject>Pharmacology. Drug treatments</subject><subject>Poverty - economics</subject><subject>Poverty - statistics & numerical data</subject><subject>race</subject><subject>racial disparities</subject><subject>Teenagers</subject><subject>Uterine Cervical Neoplasms - ethnology</subject><subject>Uterine Cervical Neoplasms - prevention & control</subject><subject>vaccination</subject><subject>Vaccines</subject><subject>Viral diseases</subject><issn>0149-2918</issn><issn>1879-114X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNksFu1DAQhiMEotvCK0AkhMShCR7bieMLUlW1dKVKICiImzVxbOolcRY7qbRvX0e7tFJPnDyHb8b_fJosewukBAL1x02pe-enWxOwpARYCVASAs-yFTRCFgD81_NsRYDLgkpojrLjGDeEECYr-jI7opyDEA1bZTffUJvT_GK69U67aXeao-_ytdfjYPJL1NMYYr4etqly_nd-NQ_o86-4dX0_Dnjnwhzzn6i18zi50ecBJxNfZS8s9tG8Prwn2Y_Li5vzq-L6y-f1-dl1oZmUU4FMIwNLsOLAa6xrIY2ArgXOrSVdU1mKutJUom0b0rUtr5ipOW-tZNZwyU6yD_u52zD-nU2c1OCiNn2P3oxzVGl9UsuGUJrQd0_QzTgHn9IlSggKlMuFEntKhzHGYKzaBjdg2CkgahGvNupBvFrEKwCVxKfON4f5czuY7qHvn-kEvD8AGDX2NqDXLj5yDRUp6xLhbM-ZJO7OmaCidsZr07lg9KS60f1HmE9PZiycS9_-MTsTHzdXkSqivi93spwJMAJEEMnuATwouao</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Jeudin, Patricia, MD</creator><creator>Liveright, Elizabeth, MD</creator><creator>del Carmen, Marcela G., MD</creator><creator>Perkins, Rebecca B., MD, MSc</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>2014</creationdate><title>Race, Ethnicity, and Income Factors Impacting Human Papillomavirus Vaccination rates</title><author>Jeudin, Patricia, MD ; Liveright, Elizabeth, MD ; del Carmen, Marcela G., MD ; Perkins, Rebecca B., MD, MSc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-a3ca31f0a54146a6679e71db144ff0d85f2ac5c29afb80dbb453e644bf93fe493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Biological and medical sciences</topic><topic>Cervical cancer</topic><topic>Ethnic Groups - education</topic><topic>Ethnic Groups - statistics & numerical data</topic><topic>ethnicity</topic><topic>Female</topic><topic>Health insurance</topic><topic>HPV</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization Programs - economics</topic><topic>Immunization Programs - statistics & numerical data</topic><topic>Immunization Programs - trends</topic><topic>income</topic><topic>Infectious diseases</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical Education</topic><topic>Medical sciences</topic><topic>Papillomavirus Infections - ethnology</topic><topic>Papillomavirus Infections - prevention & control</topic><topic>Papillomavirus Vaccines - administration & dosage</topic><topic>Papillomavirus Vaccines - economics</topic><topic>Pharmacology. Drug treatments</topic><topic>Poverty - economics</topic><topic>Poverty - statistics & numerical data</topic><topic>race</topic><topic>racial disparities</topic><topic>Teenagers</topic><topic>Uterine Cervical Neoplasms - ethnology</topic><topic>Uterine Cervical Neoplasms - prevention & control</topic><topic>vaccination</topic><topic>Vaccines</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jeudin, Patricia, MD</creatorcontrib><creatorcontrib>Liveright, Elizabeth, MD</creatorcontrib><creatorcontrib>del Carmen, Marcela G., MD</creatorcontrib><creatorcontrib>Perkins, Rebecca B., MD, MSc</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep (ProQuest)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jeudin, Patricia, MD</au><au>Liveright, Elizabeth, MD</au><au>del Carmen, Marcela G., MD</au><au>Perkins, Rebecca B., MD, MSc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Race, Ethnicity, and Income Factors Impacting Human Papillomavirus Vaccination rates</atitle><jtitle>Clinical therapeutics</jtitle><addtitle>Clin Ther</addtitle><date>2014</date><risdate>2014</risdate><volume>36</volume><issue>1</issue><spage>24</spage><epage>37</epage><pages>24-37</pages><issn>0149-2918</issn><eissn>1879-114X</eissn><abstract>Abstract Background Human papillomavirus (HPV) infection and cervical cancer disproportionately affect low-income and minority women. HPV vaccines have the potential to either reduce or exacerbate racial disparities in HPV-related diseases and cervical cancers, depending on the equitability of vaccine uptake. Objectives This review aims to identify barriers and facilitators of equitable uptake of HPV vaccination among low-income and minority girls. This review discusses factors related to race, ethnicity, and income that are associated with initiation and completion rates of the 3-dose HPV vaccine series and presents targets for intervention. Methods We reviewed relevant English-language literature to identify current vaccination rates and factors associated with vaccine uptake. Study findings related to race (black, Latino, Asian), and incomes were summarized. Results Current trends in the United States indicate low uptake among all adolescents, and that rates stagnated between 2011 and 2012. Low-income and minority adolescents are equally or more likely to start the HPV vaccination series than are white and higher-income adolescents, but are less likely to complete all 3 shots. Provider recommendation is a key factor in HPV vaccination, and minorities are less likely to report receiving recommendations for HPV vaccination. Conclusions As black, Hispanic, and Asian populations continue to grow in the United States over the next several decades, it is imperative that we not only improve HPV vaccination rates overall, but also focus on high-risk populations to prevent an increase in cervical cancer disparities.</abstract><cop>Bridgewater, NJ</cop><pub>Elsevier Inc</pub><pmid>24417783</pmid><doi>10.1016/j.clinthera.2013.11.001</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0149-2918 |
ispartof | Clinical therapeutics, 2014, Vol.36 (1), p.24-37 |
issn | 0149-2918 1879-114X |
language | eng |
recordid | cdi_proquest_miscellaneous_1490698022 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adolescent Biological and medical sciences Cervical cancer Ethnic Groups - education Ethnic Groups - statistics & numerical data ethnicity Female Health insurance HPV Human papillomavirus Humans Immunization Immunization Programs - economics Immunization Programs - statistics & numerical data Immunization Programs - trends income Infectious diseases Internal Medicine Male Medical Education Medical sciences Papillomavirus Infections - ethnology Papillomavirus Infections - prevention & control Papillomavirus Vaccines - administration & dosage Papillomavirus Vaccines - economics Pharmacology. Drug treatments Poverty - economics Poverty - statistics & numerical data race racial disparities Teenagers Uterine Cervical Neoplasms - ethnology Uterine Cervical Neoplasms - prevention & control vaccination Vaccines Viral diseases |
title | Race, Ethnicity, and Income Factors Impacting Human Papillomavirus Vaccination rates |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T07%3A58%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Race,%20Ethnicity,%20and%20Income%20Factors%20Impacting%20Human%20Papillomavirus%20Vaccination%20rates&rft.jtitle=Clinical%20therapeutics&rft.au=Jeudin,%20Patricia,%20MD&rft.date=2014&rft.volume=36&rft.issue=1&rft.spage=24&rft.epage=37&rft.pages=24-37&rft.issn=0149-2918&rft.eissn=1879-114X&rft_id=info:doi/10.1016/j.clinthera.2013.11.001&rft_dat=%3Cproquest_cross%3E3180614751%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1477212492&rft_id=info:pmid/24417783&rft_els_id=S0149291813010709&rfr_iscdi=true |